Form 4: Enovix CEO Rajendra Talluri Reports Share Withholding for Tax Obligations
SEC Form 4 Filing
Rajendra K. Talluri, CEO of Enovix Corp, reports withholding of 4,292 common stock shares to cover tax obligations related to vesting restricted stock units on February 8, 2025.
Summary
- On February 8, 2025, Rajendra K. Talluri, the President and CEO of Enovix Corp, had 4,292 shares of common stock withheld to satisfy tax obligations.
- This withholding was related to the vesting of restricted stock units (RSUs).
- Following the transaction, Talluri directly owns 2,267,367 shares of Enovix Corp, which includes 1,746,471 shares issuable upon the settlement of RSUs.
Sentiment
Score: 5
Explanation: This is a neutral event related to tax obligations from vesting RSUs. It doesn't indicate positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the withholding of shares for tax purposes, which is a normal part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/08/2025 | Date of transaction: withholding of shares for tax obligations related to vesting of restricted stock units. |
| 02/11/2025 | Date of report filing. |
Keywords
Enovix Corp, Rajendra Talluri, ENVX, Form 4, SEC Filing, Stock Withholding, Restricted Stock Units, RSUs, Beneficial Ownership, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.